Stock Comparison
LLY vs PFE
Eli Lilly and Company and Pfizer Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.04T
$151.09B
P/E (TTM)
39.1
34.9
Forward P/E
32.1
9.0
Price/Sales
13.0
2.4
Price/Book
30.6
1.8
EV/EBITDA
26.0
15.1
Dividend Yield
0.53%
4.81%
Profitability
Net Margin
33.53%
11.83%
Operating Margin
43.92%
23.45%
Return on Equity
102.30%
5.01%
Return on Assets
20.40%
5.78%
Growth (YoY)
Revenue Growth
47.70%
2.60%
Earnings Growth
26.20%
-10.10%
Price & Risk
Beta
0.5
0.3
52-Week High
$1,235.65
$28.08
52-Week Low
$679.67
$22.43
Analyst Target
$1,297.31
$28.63
Compare LLY and PFE your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.